ICU Ventures is the venture capital arm of ICU Group, an independent international investment company specializing in emerging markets. It invests in early-stage technology companies with strong ties to Ukraine and Eastern Europe, focusing on global software (deep tech, mobility, enterprise software) and emerging-markets fintech.
43% of their portfolio is in Fintech. Their most common stage is series-a (57% of deals). Average disclosed round size is $5.8M (across 13 rounds with reported amounts).
Portfolio
10
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
14 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Khazna | Series B | $16M | Jan 2025 |
 Respeecher | Series A | $1M | Dec 2023 |
 Plan Forward | Seed | $2M | Oct 2023 |
 Jenfi | Series B | $6.6M | May 2023 |
| Jenfi | Series A | $6.6M | May 2023 |
| Respeecher | Seed | — | Jan 2023 |
 Boardable | Series A | $2.6M | Nov 2022 |
 Adwisely | Seed | $1.5M | Jun 2022 |
| Adwisely | Seed | $1.5M | Jan 2022 |
| Jenfi | Series A | $6.3M | Aug 2021 |
 Revenue Grid | Series A | $20M | Jan 2021 |
 3DLook | Series A | $1M | Jul 2020 |
 3Dlook | Series A | $1M | Jan 2020 |
 Finja | Series A | $9M | Jan 2020 |
Top Co-Investors
Monk's Hill Ventures3 shared
Korea Investment Partners2 shared
Atlas Venture2 shared
Elevate Ventures2 shared
SID Venture Partners2 shared
Techstars2 shared
432 Legacy2 shared
Boost VC2 shared
Quona Capital2 shared
Gaingels2 shared
Cabra VC2 shared
TMT Investments2 shared
8VC1 shared
Tau Ventures1 shared
Y Combinator1 shared
Arc Labs1 shared
True Ventures1 shared
Headline1 shared
Revel Partners1 shared
The Cigna Group Ventures1 shared
Last updated: 20 October 2026